FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer
Paola Chiodelli, Daniela Coltrini, Marta Turati, Marianna Cerasuolo, Federica Maccarinelli, Sara Rezzola, Elisabetta Grillo, Arianna Giacomini, Sara Taranto, Silvia Mussi, Alessia Ligresti, Marco Presta, Roberto Ronca
Topics & Concepts
EnzalutamideProstate cancerTrampAndrogen deprivation therapyMedicineCancer researchCancerAndrogen receptorBlockadePopulationAndrogenInternal medicineOncologyReceptorHormoneEnvironmental healthProstate Cancer Treatment and ResearchFibroblast Growth Factor ResearchHippo pathway signaling and YAP/TAZ